Candriam Equities L Biotech.N USD Acc/ LU0133359157 /
| NAV03.05.2024 | Diff.+7,2800 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
|---|---|---|---|---|
| 591,6900USD | +1,25% | thesaurierend | Aktien weltweit | Candriam ▶ |
Monatliche Performance
| Jän | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez | Gesamt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2002 | - | - | - | - | - | - | - | - | -9,99 | 9,27 | 2,64 | - | - |
| 2003 | - | - | - | - | - | -6,25 | 7,90 | -0,80 | -0,09 | 2,12 | -1,24 | 6,03 | - |
| 2004 | 5,42 | 4,81 | -3,06 | -0,68 | -2,96 | 0,28 | -9,15 | 2,14 | 5,72 | -2,18 | 0,74 | 6,05 | +6,15% |
| 2005 | -3,86 | -5,24 | -4,01 | 3,01 | 6,31 | 2,82 | 10,06 | 1,21 | 2,73 | -3,43 | 5,62 | 1,27 | +16,38% |
| 2006 | 5,99 | 3,91 | -3,59 | -4,80 | -4,48 | 0,06 | -2,53 | 2,54 | 0,15 | 13,69 | 0,72 | -2,30 | +8,18% |
| 2007 | 2,24 | -3,57 | 1,98 | 7,43 | 0,04 | -5,90 | -2,87 | 1,84 | 5,47 | 2,09 | -2,86 | -5,99 | -1,10% |
| 2008 | -5,07 | -3,48 | 1,48 | 1,37 | 1,61 | -2,78 | 16,97 | -4,30 | -6,61 | -15,68 | -10,20 | 8,00 | -20,40% |
| 2009 | -1,42 | -7,01 | 6,04 | -0,52 | 2,83 | 7,05 | 29,13 | 2,56 | 1,34 | -11,29 | 7,95 | 5,16 | +43,88% |
| 2010 | 3,23 | 6,29 | 14,90 | -2,05 | -12,53 | -5,77 | 3,59 | -0,52 | 10,67 | 2,64 | -2,62 | 6,14 | +23,13% |
| 2011 | -0,68 | 0,69 | 5,87 | 4,49 | 2,90 | -1,81 | -3,60 | -8,06 | -6,72 | 7,88 | 0,66 | 1,74 | +2,10% |
| 2012 | 11,78 | 0,35 | 5,71 | 0,51 | -2,19 | 5,47 | 2,29 | 1,87 | 5,11 | -6,00 | 4,35 | -1,07 | +30,67% |
| 2013 | 9,62 | 0,98 | 8,03 | 6,05 | 3,25 | -2,79 | 14,21 | -2,47 | 9,90 | -2,84 | 6,49 | 1,57 | +63,77% |
| 2014 | 8,21 | 7,30 | -9,98 | -5,14 | 2,72 | 10,07 | -3,28 | 11,02 | -1,15 | 9,55 | 2,94 | 0,54 | +34,91% |
| 2015 | 4,43 | 4,49 | 1,81 | -5,15 | 10,69 | 0,59 | 4,13 | -10,99 | -11,43 | 7,76 | 3,39 | 0,28 | +7,62% |
| 2016 | -23,27 | -4,63 | 3,63 | 3,65 | 5,55 | -8,45 | 12,52 | -2,43 | 3,93 | -12,76 | 9,07 | -2,88 | -19,92% |
| 2017 | 5,46 | 6,80 | 0,04 | 1,04 | -2,99 | 9,33 | 2,35 | 6,77 | 0,86 | -6,65 | 0,08 | 1,42 | +26,10% |
| 2018 | 6,65 | -4,65 | -2,19 | -3,25 | 4,56 | 0,76 | 4,36 | 4,08 | -2,13 | -14,06 | 4,08 | -8,36 | -11,63% |
| 2019 | 13,08 | 3,53 | -0,61 | -4,99 | -4,51 | 9,39 | -2,25 | -2,40 | -4,55 | 11,15 | 11,92 | 2,74 | +34,38% |
| 2020 | -5,32 | -1,57 | -5,04 | 12,31 | 9,44 | 1,23 | -3,05 | 0,79 | 0,67 | -2,70 | 9,40 | 2,93 | +18,68% |
| 2021 | 1,77 | -2,64 | -4,33 | 2,67 | -2,30 | 6,29 | -1,51 | 3,84 | -4,29 | 0,11 | -4,43 | 2,36 | -3,12% |
| 2022 | -10,62 | -1,60 | 5,99 | -7,27 | -4,02 | 3,46 | 4,67 | 1,48 | -1,95 | 6,45 | 6,13 | -2,90 | -1,94% |
| 2023 | 2,87 | -5,70 | 0,20 | 2,23 | -0,99 | 1,39 | -0,62 | -0,27 | -4,53 | -6,16 | 6,11 | 13,59 | +6,77% |
| 2024 | 1,44 | 1,31 | -0,07 | -6,29 | 4,17 | - | - | - | - | - | - | - | - |
Kennzahlen
| lfd. Jahr | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | |
|---|---|---|---|---|---|
| Volatilität | 16,40% | 18,31% | 16,36% | 20,16% | 22,76% |
| Sharpe Ratio | -0,19 | 1,56 | 0,15 | -0,12 | 0,17 |
| Bester Monat | +13,59% | +13,59% | +13,59% | +13,59% | +13,59% |
| Schlechtester Monat | -6,29% | -6,29% | -6,29% | -10,62% | -10,62% |
| Maximaler Verlust | -11,10% | -11,10% | -15,90% | -29,12% | -31,06% |
| Outperformance | -6,86% | - | -1,46% | -7,50% | -4,10% |
Alle Kurse in USD
Tranchen
| Titel | Ertragstyp | Rückn. Preis | 1 Jahr | 3 Jahre | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | thesaurierend | 2.031,9800 | +7,52% | +6,74% | |
| Candriam Equities L Biotech.C EU... | thesaurierend | 218,3900 | +9,55% | - | |
| Candriam Equities L Biotech.I-H ... | thesaurierend | 2.036,2700 | +5,12% | -0,75% | |
| Candriam Equities L Biotech.I EU... | thesaurierend | 2.201,0601 | +10,28% | +19,32% | |
| Candriam Equities L Biotech.I GB... | thesaurierend | 3.397,8601 | +7,28% | +16,85% | |
| Candriam Equities L Biotech.R GB... | thesaurierend | 356,6400 | +7,58% | +20,57% | |
| Candriam Equities L Biotech.R EU... | thesaurierend | 322,0800 | +10,57% | +21,81% | |
| Candriam Equities L Biotech.R-H ... | thesaurierend | 198,6800 | +2,91% | -2,19% | |
| Candriam Equities L Biotech.V2 U... | thesaurierend | 1.818,4301 | +7,98% | +9,44% | |
| Candriam Equities L Biotech.N-H ... | thesaurierend | 147,5600 | - | - | |
| Candriam Equities L Biotech.N US... | thesaurierend | 591,6900 | +6,38% | +4,65% | |
| Candriam Equities L Biotech.I US... | thesaurierend | 5.559,2402 | +7,40% | +6,35% | |
| Candriam Equities L Biotech.C-H ... | thesaurierend | 194,8900 | +4,50% | -1,13% | |
| Candriam Equities L Biotech.R-H ... | thesaurierend | 203,1400 | +5,40% | +1,30% | |
| Candriam Equities L Biotech.R US... | thesaurierend | 263,6000 | +7,71% | +8,62% | |
| Candriam Equities L Biotechnolo... | thesaurierend | 830,4000 | +6,77% | +5,98% | |
| Candriam Equities L Biotechnolog... | ausschüttend | 758,4000 | +6,74% | +5,88% |
Performance
| lfd. Jahr | +0,25% | ||
|---|---|---|---|
| 6 Monate | +14,97% | ||
| 1 Jahr | +6,38% | ||
| 3 Jahre | +4,65% | ||
| 5 Jahre | +45,11% | ||
| seit Beginn | +748,54% | ||
| Jahr | |||
| 2023 | +6,77% | ||
| 2022 | -1,94% | ||
| 2021 | -3,12% | ||
| 2020 | +18,68% | ||
| 2019 | +34,38% | ||
| 2018 | -11,63% | ||
| 2017 | +26,10% | ||
| 2016 | -19,92% | ||
| 2015 | +7,62% | ||
